The role of heterogeneous environment and docetaxel gradient in the emergence of polyploid, mesenchymal and resistant prostate cancer cells
The ability of a population of PC3 prostate epithelial cancer cells to become resistant to docetaxel therapy and progress to a mesenchymal state remains a fundamental problem. The progression towards resistance is difficult to directly study in heterogeneous ecological environments such as tumors. In this work, we use a micro-fabricated “evolution accelerator” environment to create a complex heterogeneous yet controllable in-vitro environment with a spatially-varying drug concentration. With such a structure we observe the rapid emergence of a surprisingly large number of polyploid giant cancer cells (PGCCs) in regions of very high drug concentration, which does not occur in conventional cell culture of uniform concentration. This emergence of PGCCs in a high drug environment is due to migration of diploid epithelial cells from regions of low drug concentration, where they proliferate, to regions of high drug concentration, where they rapidly convert to PGCCs. Such a mechanism can only occur in spatially-varying rather than homogeneous environments. Further, PGCCs exhibit increased expression of the mesenchymal marker ZEB1 in the same high-drug regions where they are formed, suggesting the possible induction of an epithelial to mesenchymal transition (EMT) in these cells. This is consistent with prior work suggesting the PGCC cells are mediators of resistance in response to chemotherapeutic stress. Taken together, this work shows the key role of spatial heterogeneity and the migration of proliferative diploid cells to form PGCCs as a survival strategy for the cancer population, with implications for new therapies.
KeywordsPolyploid giant cancer cells Cancer-on-a-chip Tumor microenvironment Chemotherapy gradient Cell migration Metastasis
Polyploid giant cancer cell
Zinc finger E-box-binding homeobox 1
We would like to thank fruitful discussions with Dr. Yibin Kang. This work was supported by NSF PHY-1659940.
Compliance with ethical standards
Conflict of interests
The authors declare no potential conflict of interests.
- 1.Wolberg WH, Nick Street W, Mangasarian OL (1999) Importance of nuclear morphology in breast cancer prognosis. Clin Cancer Res 5(11):3542–3548Google Scholar
- 3.Erenpreisa J, Ivanov A, Wheatley SP, Kosmacek EA, Ianzini F, Anisimov AP, Mackey M, Davis PJ, Plakhins G, Illidge TM (2008) Endopolyploidy in irradiated p53-deficient tumour cell lines: persistence of cell division activity in giant cells expressing Aurora-B kinase. Cell Biol Int 32(9):1044–1056CrossRefGoogle Scholar
- 12.Zhang S, Mercado-Uribe I, Hanash S, Liu J (2013) ITRAQ-based proteomic analysis of polyploid giant cancer cells and budding progeny cells reveals several distinct pathways for ovarian cancer development. PLoS ONE 8(11):1–16Google Scholar
- 14.Lopez-Sánchez LM, Jimenez C, Valverde A, Hernandez V, Peñarando J, Martinez A, Lopez-Pedrera C, Muñoz-Castañeda JR, Juan R, Aranda E, Rodriguez-Ariza A (2014) CoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancer. PLoS ONE 9(6):e99143CrossRefGoogle Scholar
- 18.Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, Schumann T, Wilkinson JE, Zaslavsky A, Li H, Maher CA, Daignault-Newton S, Healy PN, Pienta KJ (2013) Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS ONE 8(10):e76773CrossRefGoogle Scholar
- 23.Lee HH, Bellat V, Law B (2017) Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer. PLoS ONE 12(2):1–17Google Scholar
- 31.Mango RL, van Deventer HW, Wu QP, Serody JS (2009) Pulmonary stromal cells expressing cc-chemokine receptor 5 promote metastasis via erythroid differentiation regulator 1. Blood 114(22):3601–3601Google Scholar